UBS Group Issues Positive Forecast for Healthpeak Properties (NYSE:DOC) Stock Price

Key Points

• UBS raised Healthpeak Properties’ price target from $20 to $22 but maintained a Neutral rating, implying about 7.9% upside from the then-current share price.
• Analyst sentiment overall remains cautious: MarketBeat’s consensus rating is Hold, with an average price target of $21.60.
• In its latest quarter, Healthpeak’s revenue rose 16.3% year over year and topped estimates, while reported EPS of $0.02 fell short of the $0.43 consensus.

Healthpeak Properties (NYSE:DOC - Get Free Report) had its price target upped by equities researchers at UBS Group from $20.00 to $22.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has a "neutral" rating on the real estate investment trust's stock. UBS Group's price objective would indicate a potential upside of 7.87% from the stock's current price.

DOC has been the subject of several other research reports. Weiss Ratings upgraded Healthpeak Properties from a "hold (c)" rating to a "hold (c+)" rating in a research report on Monday. Royal Bank Of Canada increased their target price on Healthpeak Properties from $21.00 to $24.00 and gave the stock an "outperform" rating in a report on Monday, August 10th. Wells Fargo & Company lowered their target price on Healthpeak Properties from $22.00 to $19.00 and set an "equal weight" rating for the company in a research note on Monday, October 19th. Cantor Fitzgerald lowered their target price on Healthpeak Properties from $23.00 to $21.00 and set a "neutral" rating for the company in a research note on Wednesday, November 4th. Finally, Jefferies Financial Group initiated coverage on Healthpeak Properties in a report on Tuesday, September 15th. They issued a "hold" rating and a $21.00 price target for the company. Four analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $21.60.

Healthpeak Properties Price Performance

Healthpeak Properties stock traded down $0.02 during trading hours on Wednesday, hitting $20.39. 3,506,235 shares of the stock were exchanged, compared to its average volume of 7,634,237. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.29 and a current ratio of 1.29. The stock has a market capitalization of $14.06 billion, a P/E ratio of 37.77, a P/E/G ratio of 2.54 and a beta of 1.01. Healthpeak Properties has a 12 month low of $15.70 and a 12 month high of $22.95. The business's 50-day moving average is $19.73 and its two-hundred day moving average is $19.22.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its earnings results on Monday, November 2nd. The real estate investment trust reported $0.02 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.43 by ($0.41). The firm had revenue of $820.89 million during the quarter, compared to the consensus estimate of $739.18 million. Healthpeak Properties had a net margin of 12.32% and a return on equity of 4.04%. The business's revenue was up 16.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.46 EPS. Equities research analysts expect that Healthpeak Properties will post 1.77 EPS for the current fiscal year.

Insider Buying and Selling

In other news, EVP Ankit Patadia sold 6,115 shares of Healthpeak Properties stock in a transaction on Monday, November 9th. The stock was sold at an average price of $20.78, for a total value of $127,069.70. Following the completion of the sale, the executive vice president directly owned 2,838 shares of the company's stock, valued at approximately $58,973.64. This trade represents a 68.30% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.23% of the company's stock.

Hedge Funds Weigh In On Healthpeak Properties

Several large investors have recently made changes to their positions in DOC. Private Advisor Group LLC raised its holdings in Healthpeak Properties by 733.2% during the 3rd quarter. Private Advisor Group LLC now owns 95,365 shares of the real estate investment trust's stock worth $1,904,000 after purchasing an additional 83,920 shares during the last quarter. Boston Partners boosted its stake in shares of Healthpeak Properties by 157.1% in the 3rd quarter. Boston Partners now owns 429,245 shares of the real estate investment trust's stock valued at $8,572,000 after purchasing an additional 262,268 shares during the last quarter. Composition Wealth LLC acquired a new stake in shares of Healthpeak Properties during the 3rd quarter worth approximately $223,000. Cibc World Market Inc. grew its position in shares of Healthpeak Properties by 2.7% during the 3rd quarter. Cibc World Market Inc. now owns 75,100 shares of the real estate investment trust's stock worth $1,500,000 after buying an additional 1,993 shares during the period. Finally, Edgestream Partners L.P. acquired a new stake in shares of Healthpeak Properties during the 3rd quarter worth approximately $288,000. Institutional investors and hedge funds own 93.57% of the company's stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc. is a real estate investment trust that owns and operates properties serving the healthcare and life sciences industries. Its portfolio includes outpatient medical buildings, life science facilities and senior housing communities. The company's properties are located across the United States, with investments in major healthcare and life science markets. In 2024, Healthpeak completed its merger with Physicians Realty Trust, expanding its portfolio of outpatient medical properties.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.